Speaker

Dr. Mohan Chellappa

Dr Mohan Chellappa is the President, Global Ventures, and Executive Vice President, Johns Hopkins Medicine International. A founding member of Johns Hopkins Medicine International since 1997, he is involved in the development of international clinical consultancy activities, especially in the area of clinical care program development, quality systems implementation and utilization of information technology in healthcare.

Dr Chellappa has been instrumental in securing and establishing various clinical, management and enterprise developmental initiatives and engagements of Johns Hopkins Medicine globally, one of the first ones being the key relationship in UAE for the establishment of relationship with Tawam Hospital, which later on lead to be the hall mark of Johns Hopkins relationships in Gulf Council Countries. Another notable achievement is the establishment of Johns Hopkins Aramco Healthcare, a joint venture between Johns Hopkins Medicine International and Aramco, the world’s largest energy company. Dr Chellappa helped to establish Johns Hopkins Medicine International presence in several countries – Brazil, Peru, Colombia, Canada, UK, Turkey, Lebanon, Japan, Mexico, China and Vietnam.

A surgeon by profession, he is a Fellow of the Royal College of Surgeons Edinburgh and Fellow of the American College of Surgeons, in addition to holding a business degree. He has a wide surgical experience, having worked in countries such as India, Malaysia, Singapore, UK and USA. Chellappa underwent special training in Surgical Gastroenterology in University of Leeds and Hammersmith Hospital in 1982 and training in Liver and Kidney transplantation in University of Louvain in Brussels in 1986.

Dr Chellappa pioneered laparoscopic gastrointestinal surgery in Asia and subsequently provided training in laparoscopic techniques to many surgeons from the Mid-East and Asia Pacific Region. Through his training programs, he established a broad network of contacts with the Medical community in these countries.

Dr Chellappa has published several scientific articles including a chapter in the book - “Disorders of Spleen” edited by Prof Alfred Cuschieri, Dundee, Scotland, Blackwell Scientific Publications.

He is an avid follower of technology and one of the founders of QSensei, a company in search technology. He has been part of the Artificial intelligence consortium for Healthcare in gulf council country.

He serves on the board of HCL Healthcare and currently serves as a founding member on the board of Johns Hopkins Aramco Healthcare.

He has a special interest in effectiveness of corporate boards and recently completed a program in that area in Harvard Business School.